Flow Cytometry in Drug Toxicity Assessment

As modern therapeutics increasingly target the immune system—through monoclonal antibodies, antibody–drug conjugates (ADCs), bispecific antibodies, and cell-based therapies—drug toxicity has become more complex, immune-mediated, and mechanism-dependent. Traditional safety assays often lack the resolution to explain why toxicity occurs, limiting their value for risk mitigation and candidate optimization.

Flow cytometry has emerged as a core analytical platform for drug toxicity assessment, offering unparalleled insight into immune cell composition, activation state, functional responses, and injury mechanisms—all at the single-cell level.

Immune Cell Subset Analysis: Identifying Cellular Targets of Toxicity

Immune cell subsets represent the primary cellular targets and mediators of immunotoxicity. Drug-induced depletion, expansion, or aberrant activation of specific immune populations often precedes overt tissue damage and clinical adverse events. Such changes may reflect off-target effects, excessive immune stimulation, or loss of immune regulation.

Flow cytometry is the gold-standard method for immune subset analysis, enabling:

• Quantitative enumeration of major immune populations (T cells, B cells, NK cells, myeloid cells)
• Resolution of functional subsets, such as effector, memory, regulatory, or exhausted cells
• Assessment of activation, proliferation, apoptosis, and viability within defined cell types

By linking immune cell composition and functional state to drug exposure, flow cytometry helps identify which cells are affected, how they are perturbed, and whether those changes are consistent with a toxicity mechanism.

Cytokine Analysis: Linking Cellular Activation to Systemic Inflammation

Cytokines act as amplifiers of immune-mediated toxicity, linking cellular activation to systemic inflammatory responses. Excessive or uncontrolled cytokine release is a central driver of inflammatory toxicity and cytokine release syndrome (CRS) associated with immune-engaging therapeutics.

Flow cytometry extends cytokine analysis beyond concentration measurements by identifying the cellular sources and activation context of cytokine production. Flow-based approaches support:

• Intracellular cytokine detection within defined immune cell subsets
• Correlation of cytokine production with activation or exhaustion markers
• Multiplex cytokine profiling compatible with cellular phenotyping

By connecting cytokine output to specific immune populations, flow cytometry transforms cytokine data into mechanistic indicators of inflammatory toxicity.

Popular Targets